Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00758368|
Recruitment Status : Withdrawn (Inadequate support to conduct the study)
First Posted : September 25, 2008
Last Update Posted : November 2, 2018
Oregon Health and Science University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
John G. Nutt, Oregon Health and Science University
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||June 2011|
|Actual Study Completion Date :||June 2011|
Manson AJ, Turner K, Lees AJ. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients. Mov Disord. 2002 Nov;17(6):1235-41.
Stocchi F, Ruggieri S, Vacca L, Olanow CW. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain. 2002 Sep;125(Pt 9):2058-66.